N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide:: A potent and selective dopamine D4 ligand

被引:22
作者
Perrone, R [1 ]
Berardi, F [1 ]
Colabufo, NA [1 ]
Leopoldo, M [1 ]
Tortorella, V [1 ]
机构
[1] Univ Bari, Dipartimento Farmaco Chim, I-70126 Bari, Italy
关键词
D O I
10.1021/jm981041x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of new 1-aryl-4-alkylpiperazines containing a terminal benzamide fragment or a tetralin-1-yl nucleus on the alkyl chain were synthesized and tested for binding at cloned human dopamine D-4 and D-2 receptor subtypes. A SAFIR (structure-affinity relationship) study on this series is herein discussed. The most relevant D-4 receptor affinities were displayed by N-[omega-[4-arylpiperazin-1-yl]alkyl]-methoxybenzamides (compounds 5, 16-20), their IC50 values ranging between 0.057 and 7.8 nM. Among these, N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide (17) emerged since it exhibited very high affinity for dopamine D-4 receptor (IC50 = 0.057 nM) with selectivity of >10 000 for the D-4 versus the D-2 receptor; compound 17 was also selective versus serotonin 5-HT1A and adrenergic alpha(1) receptors.
引用
收藏
页码:4903 / 4909
页数:7
相关论文
共 29 条
[1]   The preparation of n-mono-substituted and unsymmetrically disubstituted piperazines [J].
Baltzly, R ;
Buck, JS ;
Lorz, E ;
Schon, W .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1944, 66 :263-266
[2]   N-(substituted-phenyl) piperazines: Antagonists with high binding and functional selectivity for dopamine D-4 receptors [J].
Boyfield, I ;
Coldwell, MC ;
Hadley, MS ;
Healy, MAM ;
Johns, A ;
Nash, DJ ;
Riley, GJ ;
Scott, EE ;
Smith, SA ;
Stemp, G ;
Wilson, K .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (11) :1227-1232
[3]   Design and synthesis of 2-naphthoate esters as selective dopamine D-4 antagonists [J].
Boyfield, I ;
Brown, TH ;
Coldwell, MC ;
Cooper, DG ;
Hadley, MS ;
Hagan, JJ ;
Healy, MA ;
Johns, A ;
King, RJ ;
Middlemiss, DN ;
Nash, DJ ;
Riley, GJ ;
Scott, EE ;
Smith, SA ;
Stemp, G .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (10) :1946-1948
[4]   CLOZAPINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC USE IN SCHIZOPHRENIA [J].
FITTON, A ;
HEEL, RC .
DRUGS, 1990, 40 (05) :727-747
[5]   CLONING OF THE CDNA AND GENE FOR A HUMAN D2-DOPAMINE RECEPTOR [J].
GRANDY, DK ;
MARCHIONNI, MA ;
MAKAM, H ;
STOFKO, RE ;
ALFANO, M ;
FROTHINGHAM, L ;
FISCHER, JB ;
BURKEHOWIE, KJ ;
BUNZOW, JR ;
SERVER, AC ;
CIVELLI, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :9762-9766
[6]   A new series of selective dopamine D4 ligands: 3-([4-arylpiperazin-1-yl]alkylamino)-2H-1,4-benzoxazines [J].
He, XS ;
Woodruff, K ;
Brodbeck, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (18) :2399-2402
[7]   NOVEL BENZAMIDES AS SELECTIVE AND POTENT GASTRIC PROKINETIC AGENTS .1. SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF N-[(2-MORPHOLINYL)ALKYL]BENZAMIDES [J].
KATO, S ;
MORIE, T ;
HINO, K ;
KON, T ;
NARUTO, S ;
YOSHIDA, N ;
KARASAWA, T ;
MATSUMOTO, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (05) :1406-1413
[8]   CLOZAPINE-ASSOCIATED AGRANULOCYTOSIS - RISK AND ETIOLOGY [J].
KRUPP, P ;
BARNES, P .
BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 :38-40
[9]   3-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An antagonist with high affinity and selectivity for the human dopamine D-4 receptor [J].
Kulagowski, JJ ;
Broughton, HB ;
Curtis, NR ;
Mawer, IM ;
Ridgill, MP ;
Baker, R ;
Emms, F ;
Freedman, SB ;
Marwood, R ;
Patel, S ;
Patel, S ;
Ragan, CI ;
Leeson, PD .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (10) :1941-1942
[10]  
Liégeois JF, 1998, CURR MED CHEM, V5, P77